ATLASLexaria Bioscience (LEXX) earnings date: Nov 25, 2026
Lexaria Bioscience (LEXX) reports earnings for the quarter ended Aug 31, 2026 on Wed, Nov 25, 2026. Analysts expect EPS of -$0.90.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on LEXX
| Last price | $3.85 (+10.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±7.9% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Lexaria Bioscience stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Lexaria Bioscience reports on Nov 25, 2026. One email the day before, with ATLAS’s read on Lexaria Bioscience. You can switch it off at any time.
Alert me before LEXX reportsFree to start. Creating an account takes under a minute.
Notify me when Lexaria Bioscience reports
Track LEXX free Add Lexaria Bioscience to a free ATLAS watchlist and see its next report date in one place.
LEXX earnings at a glance
| Next report (confirmed) | Wed, Nov 25, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Aug 31, 2026 |
| EPS estimate | -$0.90 |
| Last report | Jul 13, 2026 · Miss |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | -3.7% |
| Average move around a report | ±8.4% (last 4) |
| Sector | Healthcare · Biotechnology |
Lexaria Bioscience earnings history: last 4 reports
Lexaria Bioscience last reported on Jul 13, 2026: EPS of -$1.20 against an estimate of -$0.90 (-33.3% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 13, 2026 | -$0.90 | -$1.20 | -33.3% | Miss | -9.3% |
| May 27, 2026 | $1.28 | $1.47 | +14.8% | Beat | -6.8% |
| Apr 13, 2026 | -$1.05 | -$0.90 | +14.3% | Beat | +12.1% |
| Jan 17, 2026 | $0.38 | $0.34 | -10.5% | Miss | +5.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for LEXX
See the fair value, the probability range and the earnings history of Lexaria Bioscience on its ATLAS page.
Lexaria Bioscience (LEXX) stock analysisPlans from €3.99 a month.
Lexaria Bioscience earnings: frequently asked questions
When does Lexaria Bioscience (LEXX) report earnings?
Lexaria Bioscience is scheduled to report on Wednesday, November 25, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for LEXX?
The consensus EPS estimate for the quarter ended Aug 31, 2026 is -$0.90 per share (USD). Estimates can change before the report.
How often does LEXX beat earnings estimates?
Of its last 4 reports with a recorded result, Lexaria Bioscience beat the EPS estimate 2 times; the average surprise was -3.7%. Past results do not predict the next one.
How much does LEXX move around earnings?
Over its last 4 reports the stock moved an average of 8.4% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did Lexaria Bioscience beat earnings estimates last quarter?
Lexaria Bioscience last reported on Jul 13, 2026: EPS of -$1.20 against an estimate of -$0.90 (-33.3% surprise), a miss.
How much does LEXX usually move in a day?
On a normal trading day the ATLAS model puts LEXX’s one-day range at about ±7.9%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 25, 2026
Educational information, not investment advice. Disclaimer